192 related articles for article (PubMed ID: 31248833)
1. Lymphedema-associated comorbidities and treatment gap.
Son A; O'Donnell TF; Izhakoff J; Gaebler JA; Niecko T; Iafrati MA
J Vasc Surg Venous Lymphat Disord; 2019 Sep; 7(5):724-730. PubMed ID: 31248833
[TBL] [Abstract][Full Text] [Related]
2. Correlation of disease comorbidity with prescribed treatment among insured U.S. lymphedema patients.
O'Donnell TF; Izhakoff J; Gaebler JA; Niecko T; Iafrati MD
J Vasc Surg Venous Lymphat Disord; 2021 Mar; 9(2):461-470. PubMed ID: 32470618
[TBL] [Abstract][Full Text] [Related]
3. Health and economic benefits of advanced pneumatic compression devices in patients with phlebolymphedema.
Lerman M; Gaebler JA; Hoy S; Izhakoff J; Gullett L; Niecko T; Karaca-Mandic P; O'Donnell T; Rockson SG
J Vasc Surg; 2019 Feb; 69(2):571-580. PubMed ID: 29914829
[TBL] [Abstract][Full Text] [Related]
4. US budget impact of increased payer adoption of the Flexitouch advanced pneumatic compression device in lymphedema patients with advanced chronic venous insufficiency and multiple infections.
Cohen A; Gaebler JA; Izhakoff J; Gullett L; Niecko T; O'Donnell T
J Med Econ; 2018 Oct; 21(10):993-1000. PubMed ID: 29975564
[TBL] [Abstract][Full Text] [Related]
5. The clinical and economic impact of chronic venous insufficiency-associated lymphedema and the prevalence of persistent edema after venous intervention.
Genet M; Labropoulos N; Gasparis A; O'Donnell T; Desai K
Phlebology; 2024 Jun; 39(5):353-358. PubMed ID: 38345282
[TBL] [Abstract][Full Text] [Related]
6. Adding Pneumatic Compression Therapy in Lower Extremity Lymphedema Increases Compliance of Treatment, While Decreasing the Infection Rate.
Soran A; Toktas O; Grassi A; Sezgin E
Lymphat Res Biol; 2022 Jun; 20(3):315-318. PubMed ID: 34652229
[No Abstract] [Full Text] [Related]
7. The Center for Vein Restoration Study on presenting symptoms, treatment modalities, and outcomes in Medicare-eligible patients with chronic venous disorders.
Pappas PJ; Lakhanpal S; Nguyen KQ; Vanjara R
J Vasc Surg Venous Lymphat Disord; 2018 Jan; 6(1):13-24. PubMed ID: 29248102
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and characteristics of lymphoedema at a wound-care clinic.
Wang W; Keast DH
J Wound Care; 2016 Apr; 25(4):S11-2, S14-5. PubMed ID: 27068342
[TBL] [Abstract][Full Text] [Related]
9. The clinical characteristics of lower extremity lymphedema in 440 patients.
Dean SM; Valenti E; Hock K; Leffler J; Compston A; Abraham WT
J Vasc Surg Venous Lymphat Disord; 2020 Sep; 8(5):851-859. PubMed ID: 31992537
[TBL] [Abstract][Full Text] [Related]
10. The Cutaneous, Net Clinical, and Health Economic Benefits of Advanced Pneumatic Compression Devices in Patients With Lymphedema.
Karaca-Mandic P; Hirsch AT; Rockson SG; Ridner SH
JAMA Dermatol; 2015 Nov; 151(11):1187-93. PubMed ID: 26444458
[TBL] [Abstract][Full Text] [Related]
11. Lymphedema Impact and Prevalence International Study: The Canadian Data.
Keast DH; Moffatt C; Janmohammad A
Lymphat Res Biol; 2019 Apr; 17(2):178-186. PubMed ID: 30995190
[No Abstract] [Full Text] [Related]
12. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Comorbid Medical Conditions in the National Cancer Database and the SEER-Medicare Database.
Lin CC; Virgo KS; Robbins AS; Jemal A; Ward EM
Ann Surg Oncol; 2016 Dec; 23(13):4139-4148. PubMed ID: 27535406
[TBL] [Abstract][Full Text] [Related]
14. Impact of lymphedema in the management of venous leg ulcers.
Moon T; O'Donnell TF; Weycker D; Iafrati M
Phlebology; 2023 Oct; 38(9):613-621. PubMed ID: 37647614
[TBL] [Abstract][Full Text] [Related]
15. Lymphedema following breast cancer treatment, including sentinel lymph node biopsy.
Armer J; Fu MR; Wainstock JM; Zagar E; Jacobs LK
Lymphology; 2004 Jun; 37(2):73-91. PubMed ID: 15328760
[TBL] [Abstract][Full Text] [Related]
16. Lymphedema prevalence and treatment benefits in cancer: impact of a therapeutic intervention on health outcomes and costs.
Brayton KM; Hirsch AT; O Brien PJ; Cheville A; Karaca-Mandic P; Rockson SG
PLoS One; 2014; 9(12):e114597. PubMed ID: 25470383
[TBL] [Abstract][Full Text] [Related]
17. Peculiar clinical features of cellulitis in peripheral lymphedema.
Suehiro K; Morikage N; Ueda K; Samura M; Takeuchi Y; Nagase T; Mizoguchi T; Hamano K
Lymphology; 2018; 51(2):47-53. PubMed ID: 30253454
[TBL] [Abstract][Full Text] [Related]
18. Age differences in post-breast cancer lymphedema signs and symptoms.
Armer J; Fu MR
Cancer Nurs; 2005; 28(3):200-7; quiz 208-9. PubMed ID: 15915063
[TBL] [Abstract][Full Text] [Related]
19. Approaches to the application and removal of compression therapy: A literature review.
Balcombe L; Miller C; McGuiness W
Br J Community Nurs; 2017 Oct; 22(Sup10):S6-S14. PubMed ID: 28961047
[TBL] [Abstract][Full Text] [Related]
20. LIMPRINT in Specialist Lymphedema Services in United Kingdom, France, Italy, and Turkey.
Keeley V; Franks P; Quere I; Mercier G; Michelini S; Cestari M; Borman P; Hughes A; Clark K; Lisle J; Benson M; Noerregaard S; Karlsmark T; Murray S; Moffatt C
Lymphat Res Biol; 2019 Apr; 17(2):141-146. PubMed ID: 30995195
[No Abstract] [Full Text] [Related]
[Next] [New Search]
